SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Wanbury - Quaterly Results

20 Oct 2021 Evaluate
The Top line for the quarter ended June 2021 of Rs. 1278.62 millions up 90.38% from Rs. 671.61 millions.The Net Loss for the quarter ended June 2021 is Rs. -8.61 millions as compared to Net Loss of Rs. -111.62 millions of corresponding quarter ended June 2020 Operating profit Margin for the quarter ended June 2021 improved to 68.54% as compared to -26.94% of corresponding quarter ended June 2020


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202106 202006 % Var 202106 202006 % Var 202103 202003 % Var
Sales 1278.62 671.61 90.38 1278.62 671.61 90.38 3925.18 3674.55 6.82
Other Income 3.05 2.63 15.97 3.05 2.63 15.97 24.04 11.40 110.88
PBIDT 68.54 -26.94 -354.42 68.54 -26.94 -354.42 204.23 245.85 -16.93
Interest 50.20 60.53 -17.07 50.20 60.53 -17.07 230.75 328.71 -29.80
PBDT 18.34 -87.47 -120.97 18.34 -87.47 -120.97 -26.52 743.54 -103.57
Depreciation 26.39 23.73 11.21 26.39 23.73 11.21 97.54 96.84 0.72
PBT -8.05 -111.20 -92.76 -8.05 -111.20 -92.76 -124.06 646.70 -119.18
TAX 0.56 0.42 33.33 0.56 0.42 33.33 2.00 2.09 -4.31
Deferred Tax 0.56 0.42 33.33 0.56 0.42 33.33 -20.68 2.09 -1089.47
PAT -8.61 -111.62 -92.29 -8.61 -111.62 -92.29 -126.06 644.61 -119.56
Equity 326.56 249.95 30.65 326.56 249.95 30.65 250.15 249.95 0.08
PBIDTM(%) 5.36 -4.01 -233.63 5.36 -4.01 -233.63 5.20 6.69 -22.23

Wanbury Share Price

259.05 -6.90 (-2.59%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×